[Melioidosis: a disease that is advancing]

Safety and Immunogenicity of 1 or 2 Additional Doses of the Adjuvanted Recombinant Zoster Vaccine Administered 5-6 Years After Primary Vaccination in Adults ≥50 Years.

Open forum infectious diseases·2026

[STIKO Recommendation: MF59-Adjuvanted Influenza Vaccine for Individuals ≥ 60 Years of Age].

Deutsche medizinische Wochenschrift (1946)·2026

Current Advances in Preclinical Patient-Derived Cultivation Models for Individualized Drug Response Prediction in Pancreatic Cancer.

Oncology research·2026

Novel L1CAM-antibody drug conjugates exert potent anti-tumor activity in preclinical models of even advanced pancreatic cancer.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18-49 Years at Increased Risk of RSV Disease Compared with Adults Aged ≥60 Years.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Immune persistence and safety of the AS01<sub>E</sub>-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in adults 50-59 years of age, including at-increased-risk adults: A randomized controlled trial.

Human vaccines & immunotherapeutics·2025

[Heart health must not be a question of socioeconomic status].

Deutsche medizinische Wochenschrift (1946)·2026

[Dangerous Overdose: Myocardial Injury from Digitoxin Intoxication].

Deutsche medizinische Wochenschrift (1946)·2026

[Key Symptoms in the Emergency Department: Fever].

Deutsche medizinische Wochenschrift (1946)·2026

[Chest pain as the presenting symptom in the emergency department].

Deutsche medizinische Wochenschrift (1946)·2026

[Abdominal pain as the presenting symptom in the emergency department].

Deutsche medizinische Wochenschrift (1946)·2026

[Dyspnea as a presenting symptom in the emergency department - From triage through rational diagnosis to evidence-based patient pathways].

Deutsche medizinische Wochenschrift (1946)·2026

Melasma Flaring and Unmasking After Treatment With a 1,927-nm Non-ablative Fractional Thulium Fiber Laser.

Cureus·2026

From Dermographism in Bracelets to Dermatophytosis in Circles: The First Case of Tinea Imbricata Diagnosed in Morocco.

Cureus·2026

Analytical validation of a multiplex PCR assay for differentiation of five clinically significant nontuberculous mycobacterial species.

Frontiers in microbiology·2026

Treatment patterns and outcomes in patients with multiple myeloma in second relapse in Colombia (freedomm): a multicenter observational study.

Frontiers in oncology·2026

Mesenteric defect closure versus non-closure after complete mesocolic excision in minimally invasive right colectomy: a retrospective study.

International journal of colorectal disease·2026

Applying the Moving Epidemic Method to Emergency Department Syndromic Surveillance to identify the Start of Influenza Seasons in New South Wales, Australia.

Influenza and other respiratory viruses·2026

Related Experiment Videos

[Melioidosis: a disease that is advancing]

Related Concept Videos

Safety and Immunogenicity of 1 or 2 Additional Doses of the Adjuvanted Recombinant Zoster Vaccine Administered 5-6 Years After Primary Vaccination in Adults ≥50 Years.

[STIKO Recommendation: MF59-Adjuvanted Influenza Vaccine for Individuals ≥ 60 Years of Age].

Current Advances in Preclinical Patient-Derived Cultivation Models for Individualized Drug Response Prediction in Pancreatic Cancer.

Novel L1CAM-antibody drug conjugates exert potent anti-tumor activity in preclinical models of even advanced pancreatic cancer.

Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18-49 Years at Increased Risk of RSV Disease Compared with Adults Aged ≥60 Years.

Immune persistence and safety of the AS01<sub>E</sub>-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in adults 50-59 years of age, including at-increased-risk adults: A randomized controlled trial.

[Heart health must not be a question of socioeconomic status].

[Dangerous Overdose: Myocardial Injury from Digitoxin Intoxication].

[Key Symptoms in the Emergency Department: Fever].

[Chest pain as the presenting symptom in the emergency department].

[Abdominal pain as the presenting symptom in the emergency department].

[Dyspnea as a presenting symptom in the emergency department - From triage through rational diagnosis to evidence-based patient pathways].

Melasma Flaring and Unmasking After Treatment With a 1,927-nm Non-ablative Fractional Thulium Fiber Laser.

From Dermographism in Bracelets to Dermatophytosis in Circles: The First Case of Tinea Imbricata Diagnosed in Morocco.

Analytical validation of a multiplex PCR assay for differentiation of five clinically significant nontuberculous mycobacterial species.

Treatment patterns and outcomes in patients with multiple myeloma in second relapse in Colombia (freedomm): a multicenter observational study.

Mesenteric defect closure versus non-closure after complete mesocolic excision in minimally invasive right colectomy: a retrospective study.

Applying the Moving Epidemic Method to Emergency Department Syndromic Surveillance to identify the Start of Influenza Seasons in New South Wales, Australia.

Related Experiment Videos

[Melioidosis: a disease that is advancing]

Related Concept Videos

Related Articles